U.S. BioDefense Signs Agreement to Evaluate and Option to License Adult Stem Cell Sorting and Enrichment Patent Rights Applications Related to Gene Therapy and Bioengineered Skin Process Now in FDA Proof of Concept Developed in Part by A $1.25 Million Grant From The National Institute of Dental and Craniofacial Research, Part of The National Institutes of Health
January 25, 2005 08:30 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Jan. 25, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDF) is pleased to announce today that it has signed an option license agreement with a major university and will now...
U.S. BioDefense to Launch Open Source Platform for Rapid Stem Cell Research and Development
January 21, 2005 07:45 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Jan. 21, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) announced today that it is developing an Open Source Stem Cell Research Platform to leverage the distributed...
U.S. BioDefense Files 'Stem Cell Technology and Autologous Bioengineered Skin for Medical Countermeasure' Proposal with Department of Defense Chemical Biological Defense Agency
January 18, 2005 09:00 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Jan. 18, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDF) is pleased to announce that it has met today's deadline to file its Small Business Innovation Research (SBIR) Grant...